Incidence and risk factors for central venous access port-related infection in Chinese cancer patients
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference23 articles.
1. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients;Biffi;Cancer,2001
2. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device;Biffi;Eur J Cancer,1997
3. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer;Carratalà;Antimicrob Agents Chemother,1999
4. Infectious morbidity associated with long-term use of venous access devices in patients with cancer;Groeger;Ann Intern Med,1993
5. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer—a single institution retrospective analysis;Chang;Palliat Med,2013
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review;Critical Reviews in Oncology/Hematology;2024-04
2. Management of Venous Access Port to Overcome Kinesiophobia of Patients with Malignant Tumors: A Review;Medical Science Monitor;2023-12-23
3. Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial;European Journal of Clinical Microbiology & Infectious Diseases;2023-11-23
4. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study;Infectious Diseases Now;2023-10
5. A surveillance program for long-term central venous access–associated infections in outpatient chemotherapy services;Infection Control & Hospital Epidemiology;2023-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3